P95, a service provider specialized in epidemiology, statistics and pharmacovigilance, is happy to announce that Stefaan will be joining the management team as Chief Financial Officer, effective July 6th this year.
Stefaan is a senior executive with a proven track record in leading fast-growing companies. He previously held CFO positions at MobileXpense and Luciad, two belgian PE backed software companies. He began his career as an financial auditor at PwC.
Stefaan is a qualified accountant and holds a Masters’ degree in Applied Economics.
Thomas Verstraeten, managing director of P95 said ‘I’m very excited to have Stefaan join our management team. Stefaan brings us a wealth of experience in supporting SMEs like ours to achieve steady growth. Since we started 9 years ago we have seen our turnover, number of staff, diversity of expertise and scope of work significantly increase. Stefaan will be key in supporting us further on this growth trajectory and enabling us to better serve our ever increasing number of clients.’ Stefaan stated, ‘I look forward to joining P95 and leading its finance organization to contribute to P95’s future success as the company is rapidly scaling its operations.’
P95 is a service provider, headquartered in Leuven, Belgium with staff in various European locations. Specialised in the epidemiology of infectious diseases and vaccine development, P95 supports public health agencies, vaccine manufacturers and others in setting up, conducting and analysing epidemiological studies and real world data as well as pharmacovigilance related activities. P95 is part of several Innovative Medicines Innovation (IMI) projects, including DRIVE (www.drive-eu.org) and VITAL (www.vital-imi.eu) and has recently won an award for 196 thousand Euros from VLAIO to support its development of artificial intelligence to better interpret real life data in support of vaccine development. P95 staff have co-authored over 65 peer reviewed publications.